 In a release issued under the same headline on Monday, February 3, 2020 by BOQI International Medical Inc. BIMI, in the third paragraph, the Cash Consideration to be paid should have been RMB 80,000,000 currently approximately 11,428,571, not RMB 800,000,000. Chongqing Guanzan is a Chinese medical distributor with distribution channels covering over 4,000 pharmacies, over 4,000 clinics, 50 hospitals and 130 pharmaceutical companies nationwide. 